PFM Health Sciences’s Seagate STX Stock Holding History

PFM Health Sciences’s Portfolio STX Stock Details STX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-232,051	Closed	-$10.7M	–	110
2017 Q1	$10.7M	Buy	+232,051	New	+$10.3M	0.27%	85

Other funds holding STX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

PFM Health Sciences's STX Position: Q2 2017 in Review

PFM Health Sciences sold out of Seagate (STX) in Q2 2017, closing a stake of 232,051 shares — an estimated $10.7M sold.

PFM Health Sciences first reported a position in STX in Q1 2017 and held it in 1 quarter. The position peaked at $10.7M in Q1 2017. 538 funds tracked by Wall St. Rank hold STX as of Q2 2017.

PFM Health Sciences reported no remaining Seagate position as of Q2 2017 after selling out during the quarter.
PFM Health Sciences sold 232,051 Seagate shares in Q2 2017, an estimated $10.7M.
PFM Health Sciences first reported a position in Seagate in Q1 2017 and held it in 1 quarter.
PFM Health Sciences's Seagate position peaked at $10.7M in Q1 2017.
538 funds tracked by Wall St. Rank held Seagate as of Q2 2017.

Based on PFM Health Sciences's 13F filing for Q2 2017, filed 14 Aug 2017.